- According to USP <795> for non-sterile compounding, what is the maximum beyond-use date that should be assigned to this formulation when stored under refrigeration?
Answer: 14 days from the date of preparation.
The correct answer is A. According to USP Chapter <795>, the default beyond-use date for water-containing oral formulations is not later than 14 days when stored at controlled cold temperatures (refrigerated). The individual ingredient expiration dates are only a factor if they are shorter than the default BUD. B, C, and D represent incorrect BUDs for this type of compounded preparation.
- Retail pharmacy: A label printer error omits expiration on a repackaged unit; under state board rules and USP guidance, what is required?
Answer: Correct labeling before dispensing, including appropriate beyond-use/expiration information per policy
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- Retail pharmacy: Unit-dose repackaging is done; per USP <659> and state board rules, which factor must be considered when assigning dates?
Answer: Use the earlier of manufacturer expiration or repackaging beyond-use date per policy
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- What is the most appropriate action for the pharmacist to take in this situation?
Answer: Dispense a partial supply that will be consumed before October 31, 2024, and arrange for the remainder.
The correct answer is C. A pharmacist should not dispense a quantity of medication that will be used after the product's expiration date. A 90-day supply dispensed on June 10 would last until approximately September 8, which is before the October 31 expiration date. However, best practice and many state laws prohibit dispensing a medication that expires before the patient is scheduled to complete the therapy. Dispensing a partial fill and ordering a new bottle is the most professionally responsible action to ensure the patient receives medication that is potent for the entire duration of use. A is incorrect because it is poor professional practice. B is incorrect because the drug is not truly out of stock and this action delays patient care. D is incorrect as the pharmacist should not dispense a full supply that will expire during the treatment course.
- What is the correct beyond-use date to assign to the repackaged unit-dose products?
Answer: May 31, 2025, which is the original manufacturer's expiration date.
The correct answer is B. The USP guideline for repackaged unit-dose products is to assign a beyond-use date that is the shorter of two options: 1) one year from the date of repackaging, or 2) the manufacturer's original expiration date. In this scenario, one year from repackaging would be September 1, 2025. However, the manufacturer's expiration date is May 31, 2025. Since May 31, 2025, is earlier, it must be used as the BUD. A is incorrect because it exceeds the manufacturer's expiration date. C and D are incorrect calculation methods.
- Retail pharmacy: State law is stricter than federal on dispensing short-dated meds; under FD&C Act and state board rules, which factor must be considered?
Answer: Follow both, applying the stricter state requirement when it does not conflict with federal law
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- What is the primary legal violation committed by the pharmacy in this situation?
Answer: The sale of an adulterated and/or misbranded drug.
The correct answer is C. The sale of any drug, including OTC products, after its expiration date constitutes the sale of an adulterated drug. It may also be considered misbranded because the labeling, which includes the expiration date, is no longer accurate regarding the product's stability and potency. A is incorrect as this does not constitute practicing medicine. B is incorrect because ibuprofen is an OTC drug. D is incorrect because the DEA regulates controlled substances, not OTC ibuprofen.
- According to USP standards, what is the appropriate beyond-use date (BUD) that should be placed on the prescription label?
Answer: March 1, 2025, which is one year from the date of dispensing.
The correct answer is B. For a solid oral dosage form dispensed in a prescription vial, USP guidelines recommend a beyond-use date of not more than one year from the date of dispensing, provided that this date does not exceed the manufacturer's original expiration date. Since one year from dispensing (March 1, 2025) is earlier than the manufacturer's expiration (December 31, 2026), March 1, 2025, is the correct BUD. A is incorrect as the BUD is not based on the days' supply. C is incorrect because the stability of the drug once removed from the manufacturer's original container cannot be guaranteed for that long. D is an incorrect calculation.
- Retail pharmacy: A manufacturer issues a stability extension notice to specific lots; under FD&C Act/state rules, which factor must be considered?
Answer: Apply extension only to identified lots per official manufacturer/FDA guidance and document accordingly
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- What is the primary factor that determines the beyond-use date for the reconstituted suspension?
Answer: The manufacturer's stability data for the product after reconstitution, found in the package insert.
The correct answer is B. For commercially available products that require reconstitution (like powdered antibiotics), the beyond-use date is determined by the manufacturer's stability studies and is specified in the product's package insert. This is not considered compounding from bulk ingredients, so the default USP <795> BUDs (A) do not apply. While state law (C) could impose a stricter requirement, it is the manufacturer's data that provides the standard BUD (e.g., 10 or 14 days for amoxicillin, depending on storage). The original powder's expiration date (D) applies only to the un-reconstituted product.
- Retail pharmacy: A patient requests mail delivery; stock expires in 14 days; under FD&C Act/state rules, which factor must be considered?
Answer: Consider transit time and intended duration to avoid patient using product after expiration
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- The patient asks the pharmacist when they should discard this specific in-use vial. What is the most accurate advice the pharmacist should provide?
Answer: Discard the vial 28 days after the first use, which is May 3, or as specified by the manufacturer.
The correct answer is C. Many multi-dose injectable products, including most insulins, have a specific in-use stability, which becomes the effective expiration date once the vial is punctured. For insulin glargine and many others, this is typically 28 days after first use when stored at room temperature (unless the manufacturer specifies otherwise). The original manufacturer's expiration date (A) applies only to unopened, properly stored vials. The purchase date (B) is irrelevant; the clock starts with the first puncture. The one-year rule for dispensed drugs (D) does not apply to multi-dose vials with specific in-use stability limitations.
- What is the proper procedure for returning the cephalexin capsules to the pharmacy's inventory?
Answer: Hold the returned capsules separately and dispense them first for the next cephalexin 500 mg prescription.
The correct answer is B. Federal law prohibits the commingling of different lots of a drug. Therefore, the returned capsules from lot #ABC cannot be mixed with the stock bottle of lot #DEF. The proper procedure is to keep the returned medication in its vial (or a separate stock container with the correct lot/expiration information) and use it for the next fill. A is incorrect due to the prohibition of mixing lots. C is incorrect because medications that have not left the pharmacy's control and are stored properly can typically be returned to stock. D is incorrect as the medication retains its original manufacturer's expiration date.
- Retail pharmacy: An auditor asks for expired-drug handling logs; per state board expectations and FD&C Act, what is required operationally?
Answer: Maintain inventory controls and documentation of removal/return/destruction consistent with state policy
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- According to USP guidelines for repackaging, what is the maximum allowable beyond-use date for these unit-dose packages?
Answer: One year from the date of repackaging, which is August 15, 2025.
The correct answer is C. In the absence of stability data to the contrary, USP standards state that the beyond-use date for non-sterile solid and liquid dosage forms repackaged into unit-dose containers is one year from the date of repackaging or the manufacturer's expiration date, whichever is earlier. In this case, one year from repackaging is August 15, 2025, which is earlier than March 2026. B and D represent older or alternative guidelines but are not the current prevailing USP standard. A is incorrect because the repackaging process itself introduces variables that prevent guaranteeing stability until the original expiration date.
- Which action is legally compliant when returning this medication to the pharmacy's inventory?
Answer: Place the tablets in a new stock bottle and assign the manufacturer's original expiration date of January 2026.
The correct answer is C. When returning an undelivered prescription to stock, the medication must retain the original manufacturer's expiration date or the assigned BUD, whichever is shorter. In this case, the original expiration date (Jan 2026) is appropriate. The medication should not be commingled with other lot numbers, so placing it back in the original stock bottle (A) is generally prohibited unless the lot number is verified and the pharmacy has a specific policy allowing it. Best practice is to use a separate container or dispense from the returned vial first. Assigning a new, shorter expiration date (B) is incorrect. The medication did not leave the pharmacy's control, so it can be returned to stock (D is incorrect).
- Retail pharmacy: A patient needs an antibiotic today; remaining stock expires in 20 days; under FD&C Act/state rules, which factor must be considered?
Answer: Dispense an amount expected to be consumed before expiration or obtain fresher stock promptly
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- According to federal law, what is the last day this bottle of atorvastatin can be used to dispense a prescription?
Answer: July 31, 2024, as the expiration date includes the entire last day of the specified month.
The correct answer is D. Federal law and common practice interpret a manufacturer's expiration date listed as month and year (e.g., 07/2024) to mean the drug is stable and effective through the last day of that month. Therefore, the atorvastatin can be dispensed until the end of the day on July 31, 2024. A is incorrect because internal pharmacy policy is for quality control and does not define the legal expiration date. B and C are incorrect interpretations of how expiration dates are defined.
- Retail pharmacy: A recalled lot is not involved, but product expires tomorrow; under FD&C Act/state rules, which factor must be considered?
Answer: Ensure the quantity dispensed is reasonably expected to be used before expiration and comply with state policy
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
- Retail pharmacy: A controlled substance bottle is expired; per DEA recordkeeping and state rules, what is the legal requirement for handling it?
Answer: Segregate from active stock and process disposal/return through compliant reverse distribution with required records
This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.
